Objective
The discovery and development of new drugs is very costly and attrition rates are high. Initiatives to reduce the rate of attrition during later phases are clearly desirable and if successfully implemented will reduce development costs. The InnoMed proposal addresses the complex issues associated with the future of biomédical research in the EU, and addresses ways of achieving accelerated development of, safe and more effective medicines, aiming to revitalize the European biopharmaceutical research environment. InnoMed's wide consortium base, being led by the European Federation of Pharmaceutical Industry and Associations (EFPIA), guarantee's a commitment from all the stakeholders needed to change the process of drug development in Europe. The course for addressing the necessary changes is to first develop a Strategic Research Agenda (SRA) that will encompass the whole path from discovery of a new drug target to the validation and approval stages of a new drug compound. This will be agreed by all the relevant stakeholders via meetings and workshops. Four key bottlenecks in the drug development process will be addressed: Safety Efficacy Knowledge Management Training and Education This comprehensive strategy with a detailed roadmap will lead to the deployment of a European Technology Platform (ETP). This European Technology Platform will deliver added value to the drug discovery and development process and to individual stakeholders. To ensure the relevance of the ETP InnoMed will validate it using two research proposals, AddNeuroMed, which will develop and validate novel surrogate markers based upon in vitro and in vivo models in animals and humans, using Alzheimer's disease as a testing platform. PredTox will deliver new biomarkers of toxicity and a greater understanding of mechanisms of toxicity. Both of these projects will demonstrate the viability and necessity of the ETP.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- medical and health sciencesbasic medicineneurologydementiaalzheimer
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Topic(s)
Call for proposal
FP6-2004-LIFESCIHEALTH-5
See other projects for this call
Funding Scheme
NoE - Network of ExcellenceCoordinator
BRUSSELS
Belgium
See on map
Participants (41)
BASEL
See on map
INGELHEIM
See on map
LIÈGE
See on map
COURBEVOIE
See on map
INDIANAPOLIS, INDIANA
See on map
DARMSTADT
See on map
BAGSVAERD
See on map
LONDON
See on map
WÜRZBURG
See on map
SOUTHAMPTON
See on map
1627 KUOPIO
See on map
PERUGIA
See on map
THESSALONIKI
See on map
260 ROSKILDE
See on map
SÖDERTÄLJE
See on map
STOCKHOLM
See on map
STOCKHOM
See on map
BASEL
See on map
OSS
See on map
BASEL
See on map
LONDON
See on map
COLLERETTO GIACOSA
See on map
TOULOUSE
See on map
BRENTFORD, MIDDLESEX
See on map
DUBLIN 4
See on map
COBHAM
See on map
ANKARA
See on map
LONDON
See on map
SOUTHAMPTON
See on map
BRISTOL
See on map
FRANKFURT
See on map
BRUSSELS
See on map
BEERSE
See on map
CAMBRIDGE
See on map
1188 KUOPIO
See on map
1136 STOCKHOLM
See on map
LODZ
See on map
FREMONT, CALIFORNIA
See on map
KONSTANZ
See on map
VITRY SUR SEINE
See on map
BERLIN
See on map